Furuse, Junji <br/><br/>
Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma.  [electronic resource] 

 -  Cancer science  Dec 2010 
 - 2606-11 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1349-7006 
<br/><br/><label>Standard No.: </label>10.1111/j.1349-7006.2010.01730.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Area Under Curve<br/>Carcinoma, Hepatocellular--drug therapy<br/>Disease-Free Survival<br/>Drug Combinations<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neoplasm Staging<br/>Oxonic Acid--administration & dosage<br/>Tegafur--administration & dosage